Cosmos Health Inc.
COSMNasdaqCIK 1474167Consumer discretionaryFiscal year ends Dec 31
Reports and events: 271 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2211:50 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-006396 |
| 2026-10-0917:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-006158 |
| 2026-08-2017:11 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-005195 |
| 2026-08-1816:31 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001477932-26-005146 |
| 2026-07-1616:35 ET | 8-K | 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-26-004357 |
| 2026-07-0609:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-004192 |
| 2026-06-0216:30 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001477932-26-003588 |
| 2026-05-2209:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-003403 |
| 2026-05-2016:31 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001477932-26-003357 |
| 2026-04-1611:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001477932-26-002316 |
| 2026-04-1516:34 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001477932-26-002278 |
| 2025-12-1810:23 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-25-009040 |
| 2025-11-1716:30 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-008402 |
| 2025-11-1416:32 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001477932-25-008322 |
| 2025-10-1711:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-007629 |
| 2025-10-0616:20 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-25-007365 |
| 2025-10-0106:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001477932-25-007274 |
| 2025-09-2909:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-007111 |
| 2025-08-2217:17 ET | DEF 14A | Proxy statementPeriod 2025-09-30 | 0001477932-25-006195 |
| 2025-08-1818:32 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001477932-25-005997 |
| 2025-08-1106:03 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-25-005628 |
| 2025-08-0611:29 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-25-005501 |
| 2025-06-0317:07 ET | S-1/A | Registration statement, amended | 0001477932-25-004386 |
| 2025-05-2712:06 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001477932-25-004185 |
| 2025-05-1509:20 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001477932-25-003730 |
| 2025-05-0713:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-25-003402 |
| 2025-04-1516:36 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001477932-25-002759 |
| 2025-02-2809:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001477932-25-001343 |
| 2025-02-1816:51 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-25-001107 |
| 2025-02-0716:40 ET | S-1/A | Registration statement, amended | 0001477932-25-000785 |
| 2025-01-2916:50 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001477932-25-000519 |
| 2025-01-2916:45 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0001477932-25-000517 |
| 2025-01-2208:00 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001477932-25-000373 |
| 2025-01-1406:16 ET | S-1/A | Registration statement, amended | 0001477932-25-000204 |
| 2025-01-1006:13 ET | S-1/A | Registration statement, amended | 0001477932-25-000125 |
| 2025-01-0606:04 ET | S-1/A | Registration statement, amended | 0001477932-25-000038 |
| 2024-12-1817:22 ET | S-1 | Registration statement | 0001477932-24-008191 |
| 2024-12-1016:59 ET | S-1/A | Registration statement, amended | 0001477932-24-007979 |
| 2024-11-2717:27 ET | S-1/A | Registration statement, amended | 0001477932-24-007723 |
| 2024-11-2116:30 ET | 8-K | 5.07 Shareholder vote results | 0001477932-24-007534 |
| 2024-11-1416:53 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001477932-24-007222 |
| 2024-11-1416:44 ET | S-1/A | Registration statement, amended | 0001477932-24-007216 |
| 2024-11-1216:30 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-24-007041 |
| 2024-10-2817:13 ET | S-1 | Registration statement | 0001477932-24-006693 |
| 2024-10-1814:17 ET | DEF 14A | Proxy statementPeriod 2024-11-19 | 0001477932-24-006563 |
| 2024-09-2721:08 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001477932-24-005967 |
| 2024-08-1917:05 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001477932-24-005141 |
| 2024-08-1915:50 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001477932-24-005114 |
| 2024-08-0517:09 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001477932-24-004545 |
| 2024-07-2211:26 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-24-004310 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 30, 2026, 16:09 ET. Listed shows no prices and gives no investment advice.